SR-9009, commonly referred to as Stenabolic, is a synthetic research compound that acts as a potent agonist of the Rev-Erbα nuclear receptor. By binding to Rev-Erbα, SR-9009 influences the body’s circadian rhythm and plays a key role in regulating lipid and glucose metabolism. Research suggests SR-9009 may enhance mitochondrial function, increase energy expenditure, and support improved endurance capacity.
Preclinical studies indicate potential applications in metabolic disorders, obesity, dyslipidemia, and performance research, as well as insights into circadian biology and cardiovascular health. Its unique mechanism of action distinguishes it from SARMs, making it a valuable tool for advancing research into metabolic and energy regulation.
